Mark Frydenberg

15.7k citations

207 papers · 5.5k indexed · h-index 46

Impact in

Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
Urology top 1%
- Urinary Bladder and Prostate Research

Papers in

Pulmonary and Respiratory Medicine 145
- Prostate Cancer Treatment and Research 105
- Prostate Cancer Diagnosis and Treatment 99
Urology 18
- Urinary Bladder and Prostate Research 15

Co-authors: Gail P. Risbridger Declan G. Murphy Phillip D. Stricker Nathan Lawrentschuk Keith W. Kaye Sue Evans Renea A. Taylor Jeremy Millar
Journals: British Journal of Urology (28 papers)Journal of Clinical Oncology (11 papers)ANZ Journal of Surgery (11 papers)Psycho-Oncology (10 papers)The Journal of Urology (10 papers)
Partner nations: Australia United States United Kingdom

In The Last Decade

Mark Frydenberg

198 papers receiving 5.4k citations

Peers

Countries citing papers authored by Mark Frydenberg

Since Specialization

Citations

This map shows the geographic impact of Mark Frydenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Frydenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Frydenberg more than expected).

Fields of papers citing papers by Mark Frydenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Frydenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Frydenberg. The network helps show where Mark Frydenberg may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Frydenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Frydenberg Line = papers co-authored together Mark Frydenberg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Oncological safety of testosterone replacement therapy in men with localised prostate cancer: a systematic review of observational studies British Journal of Urology ·Jordan Santucci, Peter Stapleton, Marlon Perera, Joseph Ischia, Declan G. Murphy, Damien Bolton, Nathan Lawrentschuk, Mark Frydenberg, Niranjan Sathianathen	2025	1
2	An Online Treatment Decision Aid for Men with Low-risk Prostate Cancer Eligible for Active Surveillance and Their Partners Increases the Uptake of Active Surveillance: The Navigate Randomised Controlled Trial European Urology Oncology ·Penelope Schofield, Stephen Quinn, Natalie Richards, Alan White, Fiona White, Mark Frydenberg, Suzanne K. Chambers, Louisa G. Gordon, Robert A. Gardiner, Declan G. Murphy, Matthew J. Roberts, John Yaxley, Nathan Lawrentschuk, Kevin Chu, Jeremy Millar, Jeremy Grummet, Ilona Juraskova	2025	0
3	The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis Australian Health Review ·Daniel Lindsay, Penelope Schofield, Dorean Nabukalu, Matthew J. Roberts, John Yaxley, Stephen Quinn, Natalie Richards, Mark Frydenberg, Robert A. Gardiner, Nathan Lawrentschuk, Ilona Juraskova, Declan G. Murphy, Louisa G. Gordon	2024	0
4	Prognostic implications of PSA levels at 7 months in metastatic hormone-sensitive prostate cancer treated with enzalutamide: Landmark analysis of ENZAMET (ANZUP 1304). Journal of Clinical Oncology ·Ronan Andrew Mc Laughlin, Hayley Thomas, Ian D. Davis, Robert Zielinski, Alastair Thomson, Thean Hsiang Tan, Shahneen Sandhu, M. Neil Reaume, David Pook, Francis Parnis, Scott North, Gavin Marx, John McCaffrey, Ray McDermott, Lisa G. Horvath, Mark Frydenberg, Simon Chowdhury, Kim N., Martin R. Stockler, Christopher Sweeney, (unknown)	2024	3
5	Treatment de‐intensification for low‐risk biochemical recurrence after radical prostatectomy: rational or risky? British Journal of Urology ·Matthew J. Roberts, George Hruby, Andrew Kneebone, Jarad Martin, Scott Williams, Mark Frydenberg, Declan G. Murphy, Ben Namdarian, John Yaxley, Michael S. Hofman, Ian D. Davis, Louise Emmett	2023	2
6	1792P Effects of enzalutamide on overall survival +/- early docetaxel in participants aged less than 70 yrs versus greater than or equal to 70 yrs in ENZAMET (ANZUP 1304) Annals of Oncology ·Lisa G. Horvath, Ian D. Davis, Andrew Martin, R. Zielinski, Alastair Thomson, Thean Hsiang Tan, Shahneen Sandhu, M. Neil Reaume, David Pook, Francis Parnis, Scott North, Gavin Marx, John A. McCaffrey, Ray McDermott, Nicola Jane Lawrence, Mark Frydenberg, S. Chowdhury, K.N. Chi, Martin R. Stockler, Christopher J. Sweeney	2023	2
7	Trends and variation in prostate cancer diagnosis via transperineal biopsy in Australia and New Zealand Urologic Oncology Seminars and Original Investigations ·Michael Callaghan, Matthew J. Roberts, Jeremy Grummet, Stephen Mark, Daniel Gilbourd, Mark Frydenberg, Jeremy Millar, Nathan Papa	2023	5
8	Evaluating a multicomponent survivorship programme for men with prostate cancer in Australia: a single cohort study BMJ Open ·Patsy Yates, Rob Carter, Robyn Cockerell, Donna Cowan, Cyril Dixon, Anita Lal, Robert U. Newton, Nicolas H. Hart, Daniel A. Galvão, Brenton J. Baguley, Nicholas Denniston, Tina L. Skinner, Jeremy Couper, Jon Emery, Mark Frydenberg, Weihong Liu	2022	3
9	Telehealth in surgery: an umbrella review ANZ Journal of Surgery ·Sarah Smith, Jonathan Henry W. Jacobsen, Alvin Atlas, Adeel Khoja, Joshua G. Kovoor, David Tivey, Wendy Babidge, Bridget Clancy, Erica Jacobson, Christine J. O’Neill, John B North, Roxanne Wu, Guy J. Maddern, Mark Frydenberg	2021	17
10	Proposed Delay for Safe Surgery after COVID-19 Journal of the American College of Surgeons ·Joshua G. Kovoor, David A Scott, Vanessa Beavis, Jen Kok, Andrew D. MacCormick, Robert T. A. Padbury, Thomas J. Hugh, Peter J. Hewett, Trevor G. Collinson, Mark Frydenberg	2021	2
11	An integrated multicomponent care model for men affected by prostate cancer: A feasibility study of TrueNTH Australia Psycho-Oncology ·Patsy Yates, Rob Carter, Robyn Cockerell, Donna Cowan, Cyril Dixon, Anne Magnus, Robert U. Newton, Nicolas H. Hart, Daniel A. Galvão, Brenton J. Baguley, Nicholas Denniston, Tina L. Skinner, Jeremy Couper, Jon Emery, Mark Frydenberg, Weihong Liu	2021	5
12	Proposed delay for safe surgery after COVID‐19 ANZ Journal of Surgery ·Joshua G. Kovoor, N. Ann Scott, David Tivey, Wendy Babidge, David A. Scott, Vanessa Beavis, Jen Kok, Andrew D. MacCormick, Robert T. A. Padbury, Thomas J. Hugh, Peter J. Hewett, Trevor G. Collinson, Guy J. Maddern, Mark Frydenberg	2021	18
13	Screening and testing for COVID‐19 before surgery ANZ Journal of Surgery ·Joshua G. Kovoor, David Tivey, Penny Williamson, Lorwai Tan, Helena Kopunic, Wendy Babidge, Trevor G. Collinson, Peter J. Hewett, Thomas J. Hugh, Robert T. A. Padbury, Mark Frydenberg, Richard Douglas, Jen Kok, Guy J. Maddern	2020	31
14	Detection and localisation of primary prostate cancer using ⁶⁸ gallium prostate‐specific membrane antigen positron emission tomography/computed tomography compared with multiparametric magnetic resonance imaging and radical prostatectomy specimen pathology British Journal of Urology ·Arveen Kalapara, Tatenda Nzenza, Henry Pan, Zita Ballok, Shakher Ramdave, Richard O’Sullivan, Anthony J. Ryan, Martin Cherk, Michael S. Hofman, Badrinath R. Konety, Nathan Lawrentschuk, Damien Bolton, Declan G. Murphy, Jeremy Grummet, Mark Frydenberg	2019	73
15	Robotic assisted radical prostatectomy versus open retropubic radical prostatectomy: Where do we stand in 2015? Cancer Forum ·Declan G. Murphy, Nathan Lawrentschuk, Daniel Moon, Mark Frydenberg	2015	1
16	Introducing Big Data Concepts in an Introductory Technology Course. Information Systems Education Journal ·Mark Frydenberg	2015	2
17	Assessing Expression of MUC1 and ZAG Protein Biomarkers in Prostate Biopsies Improves Prediction of Adverse Pathology Following Radical Prostatectomy Monash University Research Portal (Monash University) ·John Mills, Nazish Durrani, Mark Waldron, Catherine L. Cherry, Laurence Harewood, Mark Frydenberg, John Pedersen	2015	1
18	Human Epithelial Basal Cells Are Cells of Origin of Prostate Cancer, Independent of CD133 Status Stem Cells ·Renea A. Taylor, Roxanne Toivanen, Mark Frydenberg, John Pedersen, Lawrence Harewood, Anne T. Collins, Norman J. Maitland, Gail P. Risbridger	2012	4
19	The Relative Roles of Follicle-Stimulating Hormone and Luteinizing Hormone in Maintaining Spermatogonial Maturation and Spermiation in Normal Men The Journal of Clinical Endocrinology & Metabolism ·Kati L. Matthiesson, Robert I. McLachlan, Liza O’Donnell, Mark Frydenberg, David Robertson, Peter G. Stanton, Sarah J. Meachem	2006	57
20	The Metaplastic Effects of Estrogen on Mouse Prostate Epithelium: Proliferation of Cells with Basal Cell Phenotype¹ Endocrinology ·Gail P. Risbridger, Hong Wang, Mark Frydenberg, G R Cunha	2001	86

About Mark Frydenberg

Mark Frydenberg is a scholar working on Pulmonary and Respiratory Medicine, Urology, Oncology, Rheumatology and Surgery, having authored 207 papers that have together received 5.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (105 papers), Prostate Cancer Diagnosis and Treatment (99 papers), Bladder and Urothelial Cancer Treatments (23 papers), Cancer survivorship and care (20 papers), Global Cancer Incidence and Screening (16 papers), Urinary Bladder and Prostate Research (15 papers), Hormonal and reproductive studies (14 papers) and Urologic and reproductive health conditions (13 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.3k citations), Urology (456 citations), Oncology (1.4k citations), Rheumatology (669 citations) and Cancer Research (521 citations). Mark Frydenberg has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Gail P. Risbridger, Declan G. Murphy, Phillip D. Stricker, Nathan Lawrentschuk, Keith W. Kaye, Sue Evans, Renea A. Taylor, Jeremy Millar, Jeremy Grummet and Suzanne K. Chambers. Their work appears in journals such as British Journal of Urology, Journal of Clinical Oncology, ANZ Journal of Surgery, Psycho-Oncology and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact